JWA sensitizes P-glycoprotein-mediated drug-resistant choriocarcinoma cells to etoposide VIA JNK and mitochondrial-associated signal pathway

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 72, Issue 11-12, 2009, Pages 774-781

  Zhang, Yan ^a   Zhou, Jinhong ^b   Xu, Wenxia ^a   Li, Aiping ^b   Zhou, Jianwei ^b   Xu, Shan ^a  

^a Department of Molecular Cell Biology and Genetics ^*  (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARL6IP5 PROTEIN, HUMAN; ETOPOSIDE; GLYCOPROTEIN P; HEAT SHOCK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; SIGNAL PEPTIDE;

ARTICLE; CHORIOCARCINOMA; DOWN REGULATION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL LINE, TUMOR; CHORIOCARCINOMA; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE KINASE 4; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOGEN-ACTIVATED PROTEIN KINASES; P-GLYCOPROTEIN; SIGNAL TRANSDUCTION;

EID: 67449094289     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287390902841649     Document Type: Article

References (38)

1. Abu-Qare, A.W., Elmasry, E., and Abou-Donia, M.B. 2003. A role for P-glycoprotein in environmental toxicology. J. Toxicol. Environ. Health B 6: 279-288.
2. Adler, V., Franklin, C. C., and Kraft, A. S. 1992. Phorbol esters stimulate the phosphorylation of c-Jun but not v-Jun: Regulation by the N-terminal delta domain. Proc. Natl. Acad. Sci. USA 89:5341-5345.
3. Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., and Gottesman, M. M. 2003. P-glycoprotein: From genomics to mechanism. Oncogene 22:7468-7485.
4. Bertrand, R., Solary, E., Jenkins, J., and Pommier, Y. 1993. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors. Exp. Cell. Res. 207:388-397.
5. Bold, R. J., Termuhlen, P. M., and McConkey, D. J. 1997. Apoptosis, cancer and cancer therapy. Surg. Oncol. 6:133-142.
6. Boldt, S., Weidle, U. H., and Kolch, W. 2002. The role of MAPK pathways in the action of chemotherapeutic drugs. Carcinogenesis 23:1831-1838.
7. Clarke, P., Meintzer, S. M., Wang, Y., Moffitt, L. A., Richardson-Burns, S. M., Johnson, G. L., and Tyler, K. L. 2004. JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells. J. Virol. 78;13132-13138.
8. Dashti, S. R., Efimova, T., and Eckert, R. L. 2001. MEK6 regulates human involucrin gene expression via a p38alpha-and p38delta-dependent mechanism. J. Biol. Chem. 276:27214-27220.
9. Deschesnes, R. G., Huot, J., Valerie, K., and Landry, J. 2001. Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation. Mol. Biol. Cell 12:1569-1582.
10. Elmore, S. P., Qian, T., Grissom, S. F., and Lemasters, J. J. 2001. The mitochondrial permeability transition initiates autophagy in rat hepatocytes. FASEB J. 15:2286-2287.
11. Facompre, M., Wattez, N., Kluza, J., Lansiaux, A., and Bailly, C. 2000. Relationship between cell cycle changes and variations of the mitochondrial membrane potential induced by etoposide. Mol. Cell Biol. Res. Commun. 4:37-42.
12. Filipits, M., Stranzl, T., Pohl, G., Heinzl, H., Jager, U., Geissler, K., Fonatsch, C., Haas, O. A., Lechner, K., and Pirker, R. 2000. Drug resistance factors in acute myeloid leukemia: A comparative analysis. Leukemia 14:68-76.
13. Gottesman, M. M., Fojo, T., and Bates, S. E. 2002. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat. Rev. Cancer 2:48-58.
14. Gross, A., Yin, X. M., Wang, K., Wei, M. C., Jockel, J., Milliman, C., Erdjument-Bromage, H., Tempst, P., and Korsmeyer, S. J. 1999. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 274:1156-1163.
15. Hah, J. O. 2008. Anaplastic oligodendroglioma after childhood acute lymphoblastic leukemia: Chemotherapy and autologous peripheral blood stem cell transplantation. J. Pediatr. Hematol. Oncol. 30:764-767.
16. Hibi, M., Lin, A., Smeal, T., Minden, A., and Karin, M. 1993. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:2135-2148.
17. Hong, H. Y., and Kim, B. C. 2007. Mixed lineage kinase 3 connects reactive oxygen species to c-Jun NH2-terminal kinase-induced mitochondrial apoptosis in genipin-treated PC3 human prostate cancer cells. Biochem. Biophys. Res. Commun. 362:307-312.
18. Hu, X., Janssen, W. E., Moscinski, L. C., Bryington, M., Dangsupa, A., Rezai-Zadeh, N., Babbin, B. A., and Zuckerman, K. S. 2001. An Ikappa-Balpha inhibitor causes leukemia cell death through a p38 MAP kinasedependent, NF-kappaB-independent mechanism. Cancer Res. 61:6290-6296.
19. Kang, C. D., Ahn, B. K., Jeong, C. S., Kim, K. W., Lee, H. J., Yoo, S. D., Chung, B. S., and Kim, S. H. 2000. Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein. Exp. Cell Res. 256:300-307.
20. Kurosu, T., Takahashi, Y., Fukuda, T., Koyama, T., Miki, T., and Miura, O. 2005. p38 MAP kinase plays a role in G2 checkpoint activation and inhibits apoptosis of human B cell lymphoma cells treated with etoposide. Apoptosis 10:1111-1120.
21. Li, Z., Xu, S., Zhu, L., Xu, C. F., Zhang, Y., and Qiu, L. L. 2007. Establisment of multidrug resistant model of human choriocarcinoma in nude mice and its biological significance. Chin. J. Cancer Biother. 14:347-351.
22. Mandlekar, S., Yu, R., Tan, T. H., and Kong, A. N. 2000. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res. 60:5995-6000.
23. Mao, W. G., Liu, Z. L., Chen, R., Li, A. P., and Zhou, J. W. 2006. JWA is required for the antiproliferative and pro-apoptotic effects of all-trans retinoic acid in HeLa cells. Clin. Exp. Pharmacol. Physiol. 33:816-824.
24. Nemoto, S., Xiang, J., Huang, S., and Lin, A. 1998. Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase. J. Biol. Chem. 273:16415-16420.
25. Noh, H. T., Lee, K. H., Lee, M. A., Ko, Y. B., Hwang, S. H., and Son, S. K. 2008. Epithelioid trophoblastic tumor of paracervix and parametrium. Int. J. Gynecol. Cancer 18:843-846.
26. Revillard, J. P., Adorini, L., Goldman, M., Kabelitz, D., and Waldmann, H. 1998. Apoptosis: potential for disease therapies. Immunol. Today 19:291-293.
27. Schinkel, A. H., and Jonker, J. W. 2003. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview. Adv. Drug. Deliv. Rev. 55:3-29.
28. Solary, E., Bertrand, R., and Pommier, Y. 1994. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells. Leuk. Lymphoma 15:21-32.
29. Stadheim, T. A., and Kucera, G. L. 2002. c-Jun N-terminal kinase/stressactivated protein kinase (JNK/SAPK) is required for mitoxantrone-and anisomycin-induced apoptosis in HL-60 cells. Leukocyte Res. 26:55-65.
30. Stefanelli, C., Tantini, B., Fattori, M., Stanic, I., Pignatti, C., Clo, C., Guarnieri, C., Caldarera, C. M., Mackintosh, C. A., Pegg, A. E., and Flamigni, F. 2002. Caspase activation in etoposide-treated fibroblasts is correlated to ERK phosphorylation and both events are blocked by polyamine depletion. FEBS Lett. 527:223-228.
31. Wartenberg, M., Ling, F. C., Schallenberg, M., Baumer, A. T., Petrat, K., Hescheler, J., and Sauer, H. 2001. Down-regulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by reactive oxygen species. J. Biol. Chem. 276:17420-17428.
32. Wood, L. J., Nail, L. M., Perrin, N. A., Elsea, C. R., Fischer, A., and Druker, B. J. 2006. The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms. Biol. Res. Nurs. 8:157-169.
33. Xu, S., Zhu, L., Luo, L., Chen, Q., and Xu, C. F. 2006. Establishment of a multidrug resistant cell line JAR/VP16 of human choriocarcinoma and analysis of the expression of multidrug resistance and apoptosis-associated genes. Acta Univ. Med. Nanjing 7:485-490
34. You, B., Tranchand, B., Girard, P., Falandry, C., Ribba, B., Chabaud, S., Souquet, P. J., Court-Fortune, I., Trillet-Lenoir, V., Fournel, C., Tod, M., and Freyer, G. 2008. Etoposide pharmacokinetics and survival in patients with small cell lung cancer: A multicentre study. Lung Cancer 62:261-272.
35. Zechner, D., Craig, R., Hanford, D. S., McDonough, P. M., Sabbadini, R. A., and Glembotski, C. C. 1998. MKK6 activates myocardial cell NF-kappaB and inhibits apoptosis in a p38 mitogen-activated protein kinase-dependent manner. J. Biol. Chem. 273:8232-8239.
36. Zhou, J. W., Di, Y., Zhao, Y. H. and Wu, R. 1999. A novel cytoskeleton associated gene-cloning, identification, sequencing, regulation and tissue distribution of JWA. In Investigation on cell modulation: Signal transduction, apoptosis, and gene expression, eds. X.vS. Xu, B. F. Chen, and X. F. Tang, pp. 110-119. Beijing: Beijing Medical Military Press.
37. Zhou, J., Liu, M., Aneja, R., Chandra, R., Lage, H., and Joshi, H. C. 2006. Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer Res. 66:445-452.
38. Zhou, J., Ye, J., Zhao, X., Li, A., and Zhou, J. 2008. JWA is required for arsenic trioxide induced apoptosis in HeLa and MCF-7 cells via reactive oxygen species and mitochondria linked signal pathway. Toxicol. Appl. Pharmacol. 230:33-40.